SEC Company Response from Verrica Pharmaceuticals Inc. (VRCA) (CIK 0001660334) (VRCA) — Jun 12, 2018
Verrica Pharmaceuticals Inc. (VRCA) (CIK 0001660334)
Date: June 12, 2018 · CIK: 0001660334 · Accession: 0001193125-18-190367
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225104
Letter
10 North High Street, Suite 200
West Chester, PA 19380
VIA EDGAR
June 12, 2018
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
Attn: Ms. Christine Westbrook
Ms. Irene Paik
Ms. Bonnie Baynes
Ms. Angela Connell
Re: Verrica Pharmaceuticals Inc.
Registration Statement on Form S-1
File No. 333-225104
Acceleration Request
Requested Date:
Thursday, June 14, 2018
Requested Time:
4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-225104) (the “Registration Statement”) to become effective on June 14, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren K. DeStefano of Cooley LLP, counsel to the Registrant, at (703) 456-8034, Divakar Gupta of Cooley LLP at (212) 479-6474, or Donald Shum of Cooley LLP at (212) 479-6529.
Very truly yours,
Verrica Pharmaceuticals Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP 10 North High Street, Suite 200 West Chester, PA 19380 VIA EDGAR June 12, 2018 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 4546 Washington, D.C. 20549 Attn: Ms. Christine Westbrook Ms. Irene Paik Ms. Bonnie Baynes Ms. Angela Connell Re: Verrica Pharmaceuticals Inc. Registration Statement on Form S-1 File No. 333-225104 Acceleration Request Requested Date: Thursday, June 14, 2018 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-225104) (the “Registration Statement”) to become effective on June 14, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with Darren K. DeStefano of Cooley LLP, counsel to the Registrant, at (703) 456-8034, Divakar Gupta of Cooley LLP at (212) 479-6474, or Donald Shum of Cooley LLP at (212) 479-6529. Very truly yours, Verrica Pharmaceuticals Inc. By: /s/ Ted White Ted White President and Chief Executive Officer cc: Ted White, Verrica Pharmaceuticals Inc. Chris Degnan, Verrica Pharmaceuticals Inc. Divakar Gupta, Cooley LLP Brent Siler, Cooley LLP Nathan Ajiashvili, Latham & Watkins LLP